Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Cidara, Compass, Eli Lilly, Exelixis, Forte, H. Lundbeck, Immutep, J&J, Leap, Merck, Novo Nordisk, Pleopharma, Roche, Vertex.

Biopharmas raising money in public or private financings, including: Aptevo, Cyclacel, Eyenovia, Shuttle.

New hires and promotions in the biopharma industry, including: Candel, Galapagos, Galaxy, MBX, Medicus, Oncusp, Rapt.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Amplia, Ascentage, D&D Pharmatech, F2G.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Ark Biopharmaceutical, Bio-Thera, Celltrion, Eisai, GSK.

Biopharmas in Asia-Pacific raising money in public or private financings: Aptose, Hanmi, Jyong, Polypid, Recce.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Abtherx, China Resources Sanjiu Pharmaceutical, Escugen, Fosun, GPCR Therapeutics, Help Therapeutics, Sunrock, Teva Pharmaceuticals

New hires and promotions in biopharma in Asia-Pacific, including: Sinovac Biotech.

New hires and promotions in the med-tech industry, including: Exagen, Smith & Nephew.

Med-tech firms raising money in public or private financings, including: Archimedes Vascular.